Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Thursday, November 26, 2009, 11:37PM ET - U.S. Markets Closed for Thanksgiving Day. Dow Up 0.29% Nasdaq Up 0.32%
Daxor Corp. (DXR)On Nov 25: 14.75  Down 0.25 (1.67%)  
MORE ON DXR
Quotes
Charts
News & Info
Company
HereProfile
Analyst Coverage
Ownership
Financials

ProfileGet Profile for:
Daxor Corp.
Empire State Building 350 Fifth Avenue
Suite 7120
New York, NY 10118
United States - Map
Phone: 212-244-0555
Fax: 212-244-0806
Web Site: http://www.daxor.com

DETAILS 
Index Membership:N/A
Sector:Healthcare
Industry:Medical Instruments & Supplies
Full Time Employees:N/A

BUSINESS SUMMARY 
Daxor Corporation manufactures and markets blood volume measurement equipment in the United States. Its BVA-100 Blood Volume Analyzer is an instrument that measures human blood volume. The BVA-100 Blood Volume Analyzer is used for diagnosing and treating patients with heart failure, kidney failure, and syncope. It also helps in fluid and blood transfusion management; and in the diagnosis and treatment of polycythemia, hypertension, anemia, and chronic fatigue, as well as in presurgical evaluation, management of kidney dialysis, ultrafiltration, and blood optimization for elective surgery. Daxor Corporation markets its blood volume measurement equipment primarily to hospitals and radiology imaging centers. The company, through its subsidiary, Scientific Medical Systems, provides biotechnology services, such as cryobanking of blood and semen. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.
Key Statistics

COMPANY WEBSITES 
  • Home Page
  • Search Yahoo! for:
    More on Daxor Corp.


    CORPORATE GOVERNANCE 
    Daxor Corp.'s Corporate Governance Quotient (CGQ®) as of 6-Nov-09 is better than 30.6% of CGQ Universe companies and 15.9% of Health Care Equipment & Services companies.
    Brought to you by Institutional Shareholder Services.

    KEY EXECUTIVES 
     PayExercised
    Dr. Joseph Feldschuh M.D., 73
    Chairman, Chief Exec. Officer, Pres and Chief Scientist
    $ 281.00KN/A
    Mr. David Frankel ,
    Chief Financial Officer and Corp. Treasurer
    $ 119.00KN/A
    Mr. Stephen Feldschuh ,
    Chief Operating Officer
    $ 184.00KN/A
    Mr. Everis Engstrom ,
    VP of Engineering
    $ 132.00KN/A
    Ms. Diane M. Meegan ,
    Corp. Sec.
    N/A N/A
    Dollar amounts are as of 31-Dec-08 and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.
    View Insiders


    Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
    Get Profile for Another Symbol: Symbol Lookup
    Annual ReportsSector Analysis